Quantinuum (NASDAQ:QNT) Price Target Cut to $55.00 by Analysts at Cantor Fitzgerald

Quantinuum (NASDAQ:QNT) had its price objective lowered by equities researchers at Cantor Fitzgerald from $90.00 to $55.00 in a report released on Friday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Cantor Fitzgerald‘s price target indicates a potential upside of 84.44% from the stock’s previous close.

QNT has been the topic of several other reports. Jefferies Financial Group set a $85.00 price target on shares of Quantinuum in a report on Wednesday, August 12th. Rosenblatt Securities reaffirmed a “buy” rating and set a $155.00 target price on shares of Quantinuum in a research report on Thursday, October 22nd. Needham & Company LLC restated a “buy” rating and issued a $100.00 price target on shares of Quantinuum in a research report on Wednesday, August 12th. Yorkville Ives started coverage on shares of Quantinuum in a research report on Monday, October 5th. They set an “outperform” rating and a $60.00 price objective for the company. Finally, Morgan Stanley raised shares of Quantinuum from an “equal weight” rating to an “overweight” rating and lowered their target price for the stock from $78.00 to $62.00 in a research note on Thursday, October 15th. Thirteen research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Quantinuum has an average rating of “Moderate Buy” and an average price target of $88.46.

Quantinuum Stock Performance

Quantinuum stock opened at $29.82 on Friday. Quantinuum has a 12-month low of $28.31 and a 12-month high of $86.79. The company has a 50-day simple moving average of $43.74. The company has a market capitalization of $7.85 billion and a PE ratio of -106.50.

Quantinuum (NASDAQ:QNT) last issued its earnings results on Thursday, November 5th. The company reported ($0.29) EPS for the quarter, topping the consensus estimate of ($0.99) by $0.70. The business had revenue of $9.05 million for the quarter. Research analysts forecast that Quantinuum will post -4.76 earnings per share for the current year.

Institutional Investors Weigh In On Quantinuum

Several large investors have recently added to or reduced their stakes in QNT. CoreCap Advisors LLC acquired a new stake in shares of Quantinuum during the 3rd quarter worth approximately $32,000. Fifth Third Bancorp increased its stake in shares of Quantinuum by 1,530.2% in the 3rd quarter. Fifth Third Bancorp now owns 1,027 shares of the company’s stock valued at $49,000 after acquiring an additional 964 shares in the last quarter. IFP Advisors Inc boosted its stake in Quantinuum by 1,150.0% during the third quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock worth $60,000 after acquiring an additional 1,150 shares in the last quarter. Steel Grove Capital Advisors LLC boosted its stake in Quantinuum by 25.6% during the third quarter. Steel Grove Capital Advisors LLC now owns 5,992 shares of the company’s stock worth $288,000 after acquiring an additional 1,222 shares in the last quarter. Finally, SBI Securities Co. Ltd. grew its holdings in Quantinuum by 52.8% in the third quarter. SBI Securities Co. Ltd. now owns 6,778 shares of the company’s stock worth $326,000 after purchasing an additional 2,343 shares during the period.

More Quantinuum News

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Raised revenue outlook and strong growth: Third-quarter revenue increased 233% year over year, and Quantinuum raised its FY2026 revenue outlook. It also reported a loss of $0.29 per share, narrower than the $0.99 loss analysts expected. Quantinuum Q3 results and outlook
• Positive Sentiment: Improving commercial traction: The company said platform adoption rose nearly 20% quarter over quarter, job submissions increased tenfold year over year, and it secured its largest cloud agreement to date, alongside a hyperscaler agreement and an Oracle beta launch. Quantinuum Q3 results and outlook
• Positive Sentiment: Broker sentiment is favorable: Wall Street brokerages collectively rate QNT “Moderate Buy,” which may support investor confidence. Quantinuum analyst rating
• Neutral Sentiment: Long-term technology roadmap: Quantinuum outlined Nexus, a developer platform intended to connect application development with its hardware, including the Apollo fault-tolerant system planned for 2029. The roadmap offers potential but depends on future execution. Nexus roadmap announcement
• Negative Sentiment: Losses persist: Despite beating the quarterly EPS estimate, QNT remained unprofitable, reporting a $0.29-per-share loss. Continued losses could weigh on investor sentiment as the company works to scale its business. Quantinuum quarterly earnings report

Quantinuum Company Profile

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.